MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,862 | -76.2% | 25,088 | -38.4% | 0.00% | -80.0% |
| Q2 2023 | $134,035 | -52.8% | 40,740 | -41.1% | 0.01% | -58.3% |
| Q1 2023 | $284,248 | -13.4% | 69,160 | +23.5% | 0.01% | -40.0% |
| Q4 2022 | $328,172 | -16.9% | 56,002 | -4.3% | 0.02% | -20.0% |
| Q3 2022 | $395,000 | +887.5% | 58,500 | +477.6% | 0.02% | +1150.0% |
| Q1 2022 | $40,000 | -68.8% | 10,128 | -50.6% | 0.00% | -66.7% |
| Q4 2021 | $128,000 | -78.4% | 20,500 | -53.0% | 0.01% | -84.2% |
| Q2 2021 | $592,000 | +208.3% | 43,592 | +267.6% | 0.04% | +280.0% |
| Q1 2021 | $192,000 | – | 11,860 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |